4 months ago, all those who chose the 🔴 "red pill" 💊 were right.


AVAXUSDT price has dropped to the buying zone of $18.7-23.7
So, if you believe in #Avalanche project, the
AVAX price now is "tasty" with the prospect of growth at least x2 by the end of the year.
_____________________
Did you like our analysis? Leave a comment, like, and follow to get more

So, if you believe in #Avalanche project, the
_____________________
Did you like our analysis? Leave a comment, like, and follow to get more
Trade active
Go...go... Trade active
And also the price of #AVAXUSDT was kept above the liquidity zone, and at the same time above the purchase zone, which we wrote about earlier.
So what do you think, is it safe to take #Avalanche token long now?
Yes 👍 No 👎
Trade active
The idea written months ago for 🔴 Now we are in the final stage of testing the “strength” of the purchase area.
The #AVAXUSDT purchase zone itself has become narrower: $20.8-23.8, it's no longer possible to go lower)
And #Avalanche itself promised some kind of “trendy anonymous cryptocurrency card” for the mass market. While we are waiting for it, write your thoughts and expectations in the comments)
Trade closed: target reached
Be careful
🎁 -20% on ALL trading fees OKX
okx.com/join/20PSTRADE
🔥V-I-P cutt.ly/PwkLhT56
👍Daily bitcoin reviews here💲 cutt.ly/3wnaaG4s
🔵Telegram t.me/pstrade_eng
okx.com/join/20PSTRADE
🔥V-I-P cutt.ly/PwkLhT56
👍Daily bitcoin reviews here💲 cutt.ly/3wnaaG4s
🔵Telegram t.me/pstrade_eng
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🎁 -20% on ALL trading fees OKX
okx.com/join/20PSTRADE
🔥V-I-P cutt.ly/PwkLhT56
👍Daily bitcoin reviews here💲 cutt.ly/3wnaaG4s
🔵Telegram t.me/pstrade_eng
okx.com/join/20PSTRADE
🔥V-I-P cutt.ly/PwkLhT56
👍Daily bitcoin reviews here💲 cutt.ly/3wnaaG4s
🔵Telegram t.me/pstrade_eng
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.